AI-Driven Management of Type 2 Diabetes in China: Opportunities and Challenges
Zhifang He,1 Wenyu Li2 1Shanghai Xuhui Area Government of Community Office of Kangjian Xincun Street, Shanghai, People’s Republic of China; 2School of Marxism, Capital Normal University, Beijing, People’s Republic of ChinaCorrespondence: Wenyu Li, Email 13241466866@163.comAbstrac...
Saved in:
| Main Authors: | He Z, Li W |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ai-driven-management-of-type-2-diabetes-in-china-opportunities-and-cha-peer-reviewed-fulltext-article-DMSO |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Telemedicine Screening for Diabetic Retinopathy Using Digital Technology: Foreign Experience
by: D. A. Andreev, et al.
Published: (2024-11-01) -
Data privacy and protection in AI-driven healthcare
by: S Mahomed
Published: (2025-05-01) -
Advancement of artificial intelligence based treatment strategy in type 2 diabetes: A critical update
by: Aniruddha Sen, et al.
Published: (2025-06-01) -
Evaluation of ChatGPT-4 in detecting referable diabetic retinopathy using single fundus images
by: Owais Aftab, et al.
Published: (2025-07-01) -
The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions
by: Susanna Esposito, et al.
Published: (2024-12-01)